Medical Devices

Request for TOC Request for Sample
BUY NOW

U.S. Computer Aided Detection (CAD) Market – Industry Trends and Forecast to 2031

Medical Devices | Published Report | Feb 2024 | Country Level | 350 Pages | No of Tables: 32 | No of Figures: 33

Report Description

U.S. Computer Aided Detection (CAD) Market, By Product Type (Software and Services), Imaging Modality (Breast Imaging, Lung Imaging, Oncology and Radiation, Abdominal and Pelvic Imaging, Dental Imaging, Cardiovascular Imaging, and Others), Application (Cancer, Neurological Disorders, Cardiovascular Diseases, Musculoskeletal Diseases, and Others), Mode of Purchase (Group Purchase Organization and Individual), End User (Hospitals, Diagnostic Centers, Research Centers and Academic Institutes, and Others) - Industry Trends and Forecast to 2031.

U.S. Computer Aided Detection (CAD) Market Analysis and Size

The key factor fueling the market expansion is the increasing technological advancements. The rising application of CAD systems in the medical field is driving the market growth. In addition, the government initiatives for CAD systems will open up more business potential for the market. However, the major restraint impacting the market is the lack of skillful medical professionals. On the other hand, the increasing awareness regarding accurate diagnosis is expected to create opportunities for market growth.


Get Exclusive Sample Copy of this Report Here

Data Bridge Market Research analyzes that the U.S. Computer Aided Detection (CAD) market is expected to reach USD 1,826.95 million by 2031 from USD 742.32 million in 2023, growing with a CAGR of 12.0% in the forecast period of 2024 to 2031.

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable 2016-2021)

Quantitative Units

Revenue in USD Million

Segments Covered

Product Type (Software and Services), Imaging Modality (Breast Imaging, Lung Imaging, Oncology and Radiation, Abdominal and Pelvic Imaging, Dental Imaging, Cardiovascular Imaging, and Others), Application (Cancer, Neurological Disorders, Cardiovascular Diseases, Musculoskeletal Diseases, and Others), Mode of Purchase (Group Purchase Organization and Individual), End User (Hospitals, Diagnostic Centers, Research Centers and Academic Institutes, and Others)

Country Covered

U.S.

Market Players Covered

Koninklijke Philips N.V., FUJIFILM Holdings Corporation, CANON MEDICAL SYSTEMS CORPORATION, Siemens Healthcare GmbH, Median Technologies, General Electric Company, Hologic, Inc., iCAD, Inc., EDDA Technology, Inc., and Riverain Technologies among others

Market Definition

The term "Computer-Aided Detection" (CAD) describes the process of interpreting medical imaging investigations, such as X-rays, CT scans, and MRIs, by using computer algorithms and software. Areas of interest or possible abnormalities in the images are highlighted and flagged by CAD systems so that a radiologist or other healthcare provider can investigate them further. These systems analyze patterns, shapes, and densities in the images to increase diagnosis efficiency and accuracy by highlighting areas needing more examination. CAD is a useful tool in the diagnosis process that helps medical professionals comprehend and make decisions, even if it cannot replace human skills.

U.S. Computer Aided Detection (CAD) Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

  • Rising Application of Computer-Aided Detection (CAD) Systems in the Medical Field

The market for CAD systems is growing and evolving due to the growing implementation of these systems in various medical disciplines. CAD systems were widely used in radiology to identify complexities in images, such as mammograms, but they have quickly spread to many other medical specialties. The growing use of CAD systems in specialty areas other than radiology—pathology, cardiology, oncology, and neurology—indicates their adaptability and effectiveness in supporting medical personnel in a variety of disciplines. Healthcare procedures are being revolutionized by CAD's capacity to provide early identification, precise diagnosis, and treatment planning for a variety of illnesses.

The market potential of CAD applications is raised by their diversification, drawing in more healthcare professionals who are looking for diagnostic instruments that are more precise and efficient. The increasing adoption rates of CAD systems, which demonstrate their efficacy in several medical specialties, are driving technological improvements and market expansion.

The increasing adoption and use of CAD systems in a range of medical specialties highlights their revolutionary influence on the provision of healthcare. The use of these systems in a variety of specializations is growing as they show promise in facilitating earlier and more accurate diagnoses, improved treatment outcomes, and improved patient care. Thus, the rising application of CAD system in medical field is driving market growth.

  • Increasing Technological Advancements Associated with CAD

The primary factor behind the growth and expansion of the CAD market in the healthcare sector is technological advancements. These developments keep CAD systems up to date and improve their adaptability, precision, and capacity for diagnosing a wide range of medical disorders. The development of deep learning algorithms, machine learning, and Artificial Intelligence (AI) has been essential to the advancement of CAD systems. These developments make it possible for CAD software to process enormous volumes of medical imaging data at previously unheard-of speeds and precision. This results in the more accurate and dependable identification of anomalies in MRIs, CT scans, X-rays, and other imaging modalities.

CAD systems will advance in detection, adaptability, and integration with healthcare ecosystems as technological advancements continue. The market is growing as a result of the CAD industry's unwavering application of technology improvements, which have the enormous potential to revolutionize patient care, improve diagnostic capabilities, and influence the direction of healthcare. Thus, the increasing technological advancements is driving market growth.


Opportunity

  • Advanced Healthcare Infrastructure in the U.S.

The advanced healthcare infrastructure in the U.S. is a factor for creating significant opportunities in the market. In the U.S., the well-established network of hospitals and diagnostic centers, coupled with sophisticated medical facilities, provides a fertile ground for the seamless integration of CAD technologies. The robust infrastructure accelerates the adoption of CAD systems, enhancing the efficiency and accuracy of medical imaging and diagnostics.

In the U.S., the advanced healthcare infrastructure not only establishes a foundation for the implementation of CAD but also reflects a commitment to leveraging cutting-edge technologies to enhance patient care. This commitment, combined with the technological readiness of healthcare systems, creates an environment where CAD can thrive, offering advanced diagnostic capabilities that contribute to more accurate and timely medical interventions, which is expected to create opportunities for market growth.

Restraint/Challenge

  • High Cost of Computer Aided Detection (CAD) Systems

Many healthcare facilities find it difficult to integrate CAD systems into their diagnostic workflows due to the initial investment necessary for CAD system acquisition and implementation. Medical imaging-specific hardware and software are frequently needed for CAD systems. These systems might have expensive upfront costs, particularly for smaller healthcare facilities or those with tighter budgets.

The total cost of ownership includes additional expenses for continuing maintenance, updates, and licensing after the initial expenditure. The cost is increased by having to make sure the system is current with new developments and complies with legal requirements. It takes more time and resources to train healthcare workers on how to utilize CAD systems efficiently and seamlessly integrate them into current operations. There are expenses associated with this training for both the initial deployment and ongoing instruction as new features or updates are released. For CAD systems to remain updated with changing medical practices, technology breakthroughs, and regulatory requirements, regular updates and upgrades are necessary. Updates to the hardware and software are extra costs associated with keeping the system updated. Medical staff must receive ongoing training to retain their competency with CAD technology. Continual training programs come with costs for employee education and skill improvement.

Healthcare providers, especially smaller practices or institutions with limited funds, have been reluctant to use CAD systems due to their high cost. Patients' access to the advantages of CAD systems' more precise and effective diagnoses is restricted by this adoption barrier. The financial resources of healthcare institutions, particularly smaller practices or those with low resources, are strained by the cumulative effect of maintenance expenditures. Thus, the high cost of CAD systems is restraining the market growth.

U.S. Computer Aided Detection (CAD) Market Scope

The U.S. Computer Aided Detection (CAD) market is segmented into five notable segments based on product type, imaging modality, application, mode of purchase, and end user. The growth amongst these segments will help you analyse major growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Software
  • services

On the basis of product type, the U.S. Computer Aided Detection (CAD) market is segmented software and services.

Imaging Modality      

  • Oncology and Radiation
  •  Breast Imaging
  •  Lung Imaging
  •  Cardiovascular Imaging
  •  Abdominal and Pelvic Imaging
  •  Dental Imaging
  •  Others

On the basis of imaging modality, the U.S. Computer Aided Detection (CAD) market is segmented into breast imaging, lung imaging, oncology and radiation, abdominal and pelvic imaging, dental imaging, cardiovascular imaging, and others.

Application

  • Cancer
  • Neurological Disorders
  • Cardiovascular Diseases
  • Musculoskeletal Diseases
  • Others

On the basis of application, the market is segmented into cancer, neurological disorders, cardiovascular diseases, musculoskeletal diseases, and others.

Mode of Purchase

  • Group Purchase Organization
  • Individual

On the basis of mode of purchase, the U.S. Computer Aided Detection (CAD) market is segmented into group purchase organization and individual.

End User

  • Hospitals
  • Diagnostic Centers
  • Research Institutes and Academic Centers
  • Others

On the basis of end user, the U.S. Computer Aided Detection (CAD) market is segmented into hospitals, diagnostic centers, research centers and academic institutes, and others.


Competitive Landscape and U.S. Computer Aided Detection (CAD) Market Share Analysis

The U.S. Computer Aided Detection (CAD) market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, country presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus on the market.

Some of the major market players operating in the U.S. Computer Aided Detection (CAD) market are Koninklijke Philips N.V., FUJIFILM Holdings Corporation, CANON MEDICAL SYSTEMS CORPORATION, Siemens Healthcare GmbH, Median Technologies, General Electric Company, Hologic, Inc., iCAD, Inc., EDDA Technology, Inc., and Riverain Technologies, among others.


SKU-

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 DBMR MARKET POSITION GRID

2.7 MULTIVARIATE MODELLING

2.8 TYPE LIFELINE CURVE

2.9 MARKET END USER COVERAGE GRID

2.1 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 RISING APPLICATION OF COMPUTER-AIDED DETECTION (CAD) SYSTEMS IN THE MEDICAL FIELD

5.1.2 INCREASING TECHNOLOGICAL ADVANCEMENTS ASSOCIATED WITH CAD

5.1.3 GOVERNMENT INITIATIVES FOR COMPUTER AIDED DETECTION (CAD) SYSTEMS

5.2 RESTRAINTS

5.2.1 HIGH COST OF COMPUTER AIDED DETECTION (CAD) SYSTEMS

5.2.2 STRICT GUIDELINES FOR COMPUTER AIDED DETECTION (CAD)

5.3 OPPORTUNITIES

5.3.1 ADVANCED HEALTHCARE INFRASTRUCTURE OF THE COUNTRIES

5.3.2 INCREASING AWARENESS REGARDING ACCURATE DIAGNOSIS

5.4 CHALLENGE

5.4.1 DEPENDENCY ON SKILLED MEDICAL PROFESSIONALS

6 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE

6.1 OVERVIEW

6.2 SOFTWARE

6.2.1 INTEGRATED CAD

6.2.1.1 CLOUD-BASED

6.2.1.2 ON-PREMISES

6.2.2 STANDALONE CAD

6.2.2.1 CLOUD-BASED

6.2.2.2 ON-PREMISES

6.3 SERVICES

7 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY

7.1 OVERVIEW

7.2 ONCOLOGY AND RADIATION

7.2.1 BY TYPE

7.2.1.1 ONCOLOGY CAD

7.2.1.2 RADIATION THERAPY PLANNING

7.2.2 BY TUMOR TYPE

7.2.2.1 MALIGNANT

7.2.2.2 BENIGN

7.2.3 BY PRODUCT TYPE

7.2.3.1 SOFTWARE

7.2.3.2 SERVICES

7.3 BREAST IMAGING

7.3.1 BY TYPE

7.3.1.1 MAMMOGRAPHY CAD

7.3.1.2 BREAST ULTRASOUND CAD

7.3.2 BY PRODUCT TYPE

7.3.2.1 SOFTWARE

7.3.2.2 SERVICES

7.4 LUNG IMAGING

7.4.1 BY TYPE

7.4.1.1 CHEST X-RAY CAD

7.4.1.2 CHEST CT CAD ON PULMONARY NODULES

7.4.2 BY NODULE SIZE

7.4.2.1 >4MM AND <5MM

7.4.2.2 >5MM

7.4.2.3 3 MM AND < 4MM

7.4.3 BY NODULE

7.4.3.1 PART SOLID NODULES

7.4.3.2 NON- SOLID NODULES

7.4.4 BY NODULE TYPE

7.4.4.1 JUXTAPLEURAL NODULES

7.4.4.2 ISOLATED NODULES

7.4.4.3 GROUND-GLASS NODULES

7.4.5 BY PRODUCT TYPE

7.4.5.1 SOFTWARE

7.4.5.2 SERVICES

7.5 CARDIOVASCULAR IMAGING

7.5.1 BY TYPE

7.5.1.1 CARDIAC CT CAD

7.5.1.2 CARDIAC MRI CAD

7.5.2 BY PRODUCT TYPE

7.5.2.1 SOFTWARE

7.5.2.2 SERVICES

7.6 ABDOMINAL AND PELVIC IMAGING

7.6.1 BY TYPE

7.6.1.1 GASTROINTESTINAL CAD

7.6.1.2 ABDOMINAL CT CAD

7.6.1.3 KIDNEY CAD

7.6.2 BY PRODUCT TYPE

7.6.2.1 SOFTWARE

7.6.2.2 SERVICES

7.6.2.3 DENTAL IMAGING

7.6.3 BY PRODUCT TYPE

7.6.3.1 SOFTWARE

7.6.3.2 SERVICES

7.7 OTHERS

8 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 CANCER

8.2.1 BREAST CANCER

8.2.2 COLORECTAL CANCER

8.2.3 LUNG CANCER

8.2.4 PROSTATE CANCER

8.2.5 LIVER CANCER

8.2.6 BONE CANCER

8.2.7 OTHERS

8.2.7.1 SOFTWARE

8.2.7.2 SERVICES

8.3 NEUROLOGICAL DISORDERS

8.3.1 MULTIPLE SCLEROSIS

8.3.2 STROKE

8.3.3 OTHERS

8.3.3.1 SOFTWARE

8.3.3.2 SERVICES

8.4 CARDIOVASCULAR DISEASES

8.4.1 CORONARY ARTERY DISEASE

8.4.2 CONGENITAL HEART DEFECTS

8.4.3 VALVULAR HEART DISEASE

8.4.4 OTHERS

8.4.4.1 SOFTWARE

8.4.4.2 SERVICES

8.5 MUSCULOSKELETAL DISEASES

8.5.1 OSTEOARTHRITIS

8.5.2 RHEUMATOID ARTHRITIS

8.5.3 JOINT DISORDERS

8.5.4 OTHERS

8.5.4.1 SOFTWARE

8.5.4.2 SERVICES

8.6 OTHERS

9 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE

9.1 OVERVIEW

9.2 GROUP PURCHASE ORGANIZATIONS

9.3 INDIVIDUAL

10 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.2.1 PRIVATE

10.2.2 PUBLIC

10.3 DIAGNOSTIC CENTERS

10.4 RESEARCH CENTERS & ACADEMIC INSTITUTES

10.5 OTHERS

11 COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: U.S.

12 SWOT ANALYSIS

13 COMPANY PROFILES

13.1 FUJIFILM HOLDINGS CORPORATION

13.1.1 COMPANY SNAPSHOT

13.1.2 REVENUE ANALYSIS

13.1.3 PRODUCT PORTFOLIO

13.1.4 RECENT DEVELOPMENT

13.2 KONINKLIJKE PHILIPS N.V.

13.2.1 COMPANY SNAPSHOT

13.2.2 REVENUE ANALYSIS

13.2.3 PRODUCT PORTFOLIO

13.2.4 RECENT DEVELOPMENT

13.3 CANON MEDICAL SYSTEMS CORPORATION

13.3.1 COMPANY SNAPSHOT

13.3.2 REVENUE ANALYSIS

13.3.3 PRODUCT PORTFOLIO

13.3.4 RECENT DEVELOPMENT

13.4 SIEMENS HEALTHINEERS AG

13.4.1 COMPANY SNAPSHOT

13.4.2 REVENUE ANALYSIS

13.4.3 PRODUCT PORTFOLIO

13.4.4 RECENT DEVELOPMENT

13.5 MEDIAN TECHNOLOGIES.

13.5.1 COMPANY SNAPSHOT

13.5.2 REVENUE ANALYSIS

13.5.3 PRODUCT PORTFOLIO

13.5.4 RECENT DEVELOPMENT

13.6 GENERAL ELECTRIC

13.6.1 COMPANY SNAPSHOT

13.6.2 REVENUE ANALYSIS

13.6.3 PRODUCT PORTFOLIO

13.6.4 RECENT DEVELOPMENT

13.7 HOLOGIC INC.

13.7.1 COMPANY SNAPSHOT

13.7.2 REVENUE ANALYSIS

13.7.3 PRODUCT PORTFOLIO

13.7.4 RECENT DEVELOPMENT

13.8 ICAD, INC.

13.8.1 COMPANY SNAPSHOT

13.8.2 REVENUE ANALYSIS

13.8.3 PRODUCT PORTFOLIO

13.8.4 RECENT DEVELOPMENT

13.9 EDDA TECHNOLOGY, INC.

13.9.1 COMPANY SNAPSHOT

13.9.2 PRODUCT PORTFOLIO

13.9.3 RECENT DEVELOPMENT

13.1 RIVERAIN TECHNOLOGIES

13.10.1 COMPANY SNAPSHOT

13.10.2 PRODUCT PORTFOLIO

13.10.3 RECENT DEVELOPMENT

14 QUESTIONNAIRE

15 RELATED REPORTS

List of Table

TABLE 1 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 2 U.S. SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 3 U.S. INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 4 U.S. STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)

TABLE 5 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)

TABLE 6 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 7 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)

TABLE 8 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 9 U.S. BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 10 U.S. BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 11 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 12 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)

TABLE 13 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)

TABLE 14 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)

TABLE 15 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 16 U.S. CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 17 U.S. CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 18 U.S. ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 19 U.S. ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 20 U.S. DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 21 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 22 U.S. CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 23 U.S. CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 24 U.S. NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 25 U.S. NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 26 U.S. CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 27 U.S. CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 28 U.S. MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 29 U.S. MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 30 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)

TABLE 31 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 32 U.S. HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)

List of Figure

FIGURE 1 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: SEGMENTATION

FIGURE 2 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: DATA TRIANGULATION

FIGURE 3 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: DROC ANALYSIS

FIGURE 4 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: COUNTRYWISE MARKET ANALYSIS

FIGURE 5 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: DBMR MARKET POSITION GRID

FIGURE 8 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: MARKET END USER COVERAGE GRID

FIGURE 9 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: SEGMENTATION

FIGURE 10 INCREASING TECHNOLOGICAL ADVANCEMENTS ARE DRIVING THE GROWTH OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET IN THE FORECAST PERIOD OF 2024 TO 2031

FIGURE 11 SOFTWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET IN 2024 AND 2031

FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET

FIGURE 13 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2023

FIGURE 14 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2024-2031 (USD MILLION)

FIGURE 15 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, CAGR (2024-2031)

FIGURE 16 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 17 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2023

FIGURE 18 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2024-2031 (USD MILLION)

FIGURE 19 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, CAGR (2024-2031)

FIGURE 20 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, LIFELINE CURVE

FIGURE 21 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2023

FIGURE 22 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2024-2031 (USD MILLION)

FIGURE 23 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, CAGR (2024-2031)

FIGURE 24 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 25 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2023

FIGURE 26 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2024-2031 (USD MILLION)

FIGURE 27 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, CAGR (2024-2031)

FIGURE 28 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, LIFELINE CURVE

FIGURE 29 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2023

FIGURE 30 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2024-2031 (USD MILLION)

FIGURE 31 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, CAGR (2024-2031)

FIGURE 32 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, LIFELINE CURVE

FIGURE 33 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY SHARE 2023 (%)

View Infographics

FIGURE 1 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: SEGMENTATION

FIGURE 2 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: DATA TRIANGULATION

FIGURE 3 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: DROC ANALYSIS

FIGURE 4 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: COUNTRYWISE MARKET ANALYSIS

FIGURE 5 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: DBMR MARKET POSITION GRID

FIGURE 8 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: MARKET END USER COVERAGE GRID

FIGURE 9 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: SEGMENTATION

FIGURE 10 INCREASING TECHNOLOGICAL ADVANCEMENTS ARE DRIVING THE GROWTH OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET IN THE FORECAST PERIOD OF 2024 TO 2031

FIGURE 11 SOFTWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET IN 2024 AND 2031

FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET

FIGURE 13 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2023

FIGURE 14 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2024-2031 (USD MILLION)

FIGURE 15 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, CAGR (2024-2031)

FIGURE 16 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 17 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2023

FIGURE 18 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2024-2031 (USD MILLION)

FIGURE 19 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, CAGR (2024-2031)

FIGURE 20 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, LIFELINE CURVE

FIGURE 21 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2023

FIGURE 22 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2024-2031 (USD MILLION)

FIGURE 23 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, CAGR (2024-2031)

FIGURE 24 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 25 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2023

FIGURE 26 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2024-2031 (USD MILLION)

FIGURE 27 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, CAGR (2024-2031)

FIGURE 28 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, LIFELINE CURVE

FIGURE 29 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2023

FIGURE 30 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2024-2031 (USD MILLION)

FIGURE 31 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, CAGR (2024-2031)

FIGURE 32 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, LIFELINE CURVE

FIGURE 33 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY SHARE 2023 (%)

CHOOSE LICENCE TYPE
  • 2500.00
  • 2000.00
  • 1500.00
  • 3200.00
  • 5000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19